All In Biotech

Drug Trial Radar · NCT06849791

A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants

Assessment of the Relative Bioavailability of ABBV-932 Formulations in Healthy Adult Subjects

Last checked: Nov 19, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

9

Actual

Start

Feb 26, 2025

Primary completion

May 8, 2026

Study completion May 8, 2026

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Feb 27, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will assess the relative bioavailability and effect of food on pharmacokinetics of ABBV-932 oral administration in healthy adult participants.

Conditions

  • Healthy Volunteer

Interventions

  • ABBV-932Drug

    Oral Capsule

  • ABBV-932Drug

    Oral tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Plasma Concentration (Cmax) of ABBV-932Time frame: Up to approximately 6 days
  2. Time to Cmax (Tmax) of ABBV-932Time frame: Up to approximately 6 days
  3. Terminal Phase Elimination Rate Constant (Beta) of ABBV-932Time frame: Up to approximately 6 days
  4. Terminal Phase Elimination Half-Life (t1/2) of ABBV-932Time frame: Up to approximately 6 days
  5. Area Under the Concentration-Time Curve From Time 0 to Time t (AUCt) of ABBV-932Time frame: Up to approximately 6 days
  6. Area Under the Concentration-Time Curve From Time 0 to Infinity (AUCinf) of ABBV-932Time frame: Up to approximately 6 days
  7. Number of Participants Experiencing Adverse EventsTime frame: Up to approximately 180 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Acpru /Id# 266649

    Grayslake, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.